Skip to main content
IRTC logo

iRhythm Holdings, Inc.

IRTCNASDAQHealthcareMedical Devices

$108.64Today:- (-)1Y −39.85%

As of Oct 16, 2026 close

Market cap
$3.60B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$100.70$212.00
Volume (live)
-
Avg. volume (3M)
517.31K

iRhythm Holdings (IRTC) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), iRhythm Holdings generated $80.86M of operating cash flow and spent $46.34M on capital expenditures. That left free cash flow of $34.52M, or 4.6% of revenue.

iRhythm Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for iRhythm Holdings, Inc. (IRTC) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-44.55-113.29-123.41-116.16-101.36-43.83-54.57-48.28-29.42
Depreciation & Amortization26.4825.7822.1413.419.846.903.452.271.60
Deferred Income Tax0.000.000.000.000.0031.8623.7617.429.06
Stock Based Compensation88.2875.9877.2057.7454.5341.5226.2416.3310.12
Change in Working Capital-91.70-99.12-102.05-65.51-46.23-56.24-29.73-13.87-8.08
Change in Accounts Receivable-95.43-91.92-81.19-61.84-53.57-37.96-28.73-22.89-12.95
Change in Inventory-8.51-0.220.98-5.11-4.96-1.39-1.97-0.38-0.29
Change in Accounts Payable28.040.00-1.9711.486.14-3.885.60-0.190.63
Change in Other Working Capital7.06-6.97-19.86-10.05-3.90-13.01-4.649.594.53
Other Operating Activities7.06114.0476.0087.5145.476.038.99-2.931.81
Net Cash from Operating Activities80.863.39-50.10-23.01-37.75-13.76-21.86-29.07-14.91
Investing Activities
Capital Expenditures-46.34-48.94-40.42-29.83-28.07-13.55-20.46-5.18-3.56
Acquisitions0.000.000.000.000.00118.8468.820.000.00
Purchases of Investments-468.41-175.24-167.29-188.57-122.18-277.51-165.92-93.16-129.83
Sales/Maturities of Investments237.70101.20206.50165.97255.52158.6797.10132.4698.71
Other Investing Activities0.00-15.000.000.000.00-118.84-68.8239.320.09
Net Cash from Investing Activities-277.06-122.98-1.21-52.43105.26-132.39-89.2734.12-34.59
Financing Activities
Debt Repayment0.00619.840.00-21.47-11.67-1.940.003.500.00
Common Stock Issued12.618.470.0013.188.94206.03107.379.326.39
Common Stock Repurchased0.00-25.000.000.00-25.850.000.00-3.880.00
Other Financing Activities0.00-91.938.8213.18-25.8510.244.212.800.14
Net Cash from Financing Activities12.61511.388.8226.72-28.58214.32111.586.306.53
Summary
Effect of Forex Changes on Cash0.00-0.01-0.170.000.000.000.000.000.00
Net Change in Cash-183.59391.78-42.66-48.7338.9368.170.4411.35-42.97
Cash at Beginning of Period427.9636.1778.83127.5688.6320.4620.028.6751.64
Cash at End of Period244.37427.9636.1778.83127.5688.6320.4620.028.67
Free Cash Flow34.52-45.55-90.53-52.84-65.82-27.31-42.32-34.25-18.47
Supplemental Disclosures
Interest Paid9.926.392.963.321.19----
Income Taxes Paid1.200.921.130.29-----

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About iRhythm Holdings Cash Flow

What is iRhythm Holdings's free cash flow?

iRhythm Holdings generated free cash flow of $34.52M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $80.86M minus $46.34M of capital expenditures. Free cash flow equaled 4.6% of revenue.

How much does iRhythm Holdings spend on capital expenditures?

iRhythm Holdings spent $46.34M on capital expenditures in fiscal 2025, compared with $48.94M a year earlier. That equals 57.3% of operating cash flow.

Does iRhythm Holdings pay dividends or buy back shares?

iRhythm Holdings's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition